Inquiry Basket
5-Maleimidovalericacid-NHS is a widely used bioconjugation reagent in the biomedical field, which can modify molecules such as proteins and peptides by establishing long-lasting amide bonds. This facilitates the creation of targeted medication management and diagnostic tools.
| Catalog Number | Size | Price | Quantity |
|---|---|---|---|
| BADC-00504 | -- | $-- |
5-Maleimidovalericacid-NHS (MVA-NHS), a versatile crosslinker reagent, holds a significant presence in bioconjugation and biomolecular research. Here are four key applications of MVA-NHS presented with a high degree of perplexity and burstiness:
Protein-Protein Conjugation: MVA-NHS emerges as a pivotal tool for bridging diverse proteins via their thiol groups, leading to the formation of robust protein conjugates. This technique proves invaluable for crafting antibody-drug conjugates tailored for precise therapies. Leveraging MVA-NHS for conjugation not only ensures the preservation of biological activity in the connected proteins but also enables precise targeting with exceptional specificity.
Enzyme Immobilization: In the realm of biotechnology, MVA-NHS takes center stage for tethering enzymes onto solid supports like beads or columns. This strategic immobilization enhances the efficiency and control of enzymatic reactions, making them more potent. The reusability and improved stability of immobilized enzymes make them indispensable for various industrial applications, showcasing the versatility of MVA-NHS in catalyzing biotechnological advancements.
Diagnostics Development: Assuming a critical role in diagnostic assay development, MVA-NHS plays a pivotal part in linking antibodies to detection molecules such as fluorescent dyes or enzymatic reporters. The resulting conjugates, enabled by MVA-NHS, feature prominently in techniques like ELISA and immunohistochemistry, enabling highly sensitive and specific detection of biomarkers. Integrating MVA-NHS in diagnostics enhances the accuracy and reliability of diagnostic tests, setting new standards in precision and efficacy.
Drug Delivery Systems: The utility of MVA-NHS extends to the realm of drug delivery systems, excelling in linking therapeutic agents to carrier molecules such as polymers or nanoparticles. This innovative approach enables the creation of controlled-release formulations, elevating the pharmacokinetic properties of drugs to new levels. Through the stable and efficient linkage provided by MVA-NHS, the overall efficacy of therapeutic agents is significantly enhanced, ushering in a new era of precision medicine.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.
